(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.)
Plenful, a startup that wants to free pharmacists from burdensome back-office tasks, has raised $17 million.
The Series A round was led by TQ Ventures. Following Plenful’s $9 million raise that was announced in October, it brings the startup’s total funding to more than $25 million. Bessemer Venture Partners, Susa Ventures, Danaher co-founder and chairman Mitchell Rales, and existing investors also participated in the new round, according to the company.
San Francisco-based Plenful automates manual pharmacy work, such as auditing claims and entering orders, so pharmacists can focus on tasks like caring for patients, the startup’s founder and CEO Joy Liu told Endpoints News. She said Plenful will use funds to invest in sales and marketing, and further develop its product capabilities.
In an emailed statement, Andrew Marks, partner and co-founder of TQ Ventures, said Plenful’s customers say they’ve been able to grow and care for more patients as manual work is reduced.
“The ongoing pharmacy labor shortages and increasing workflow complexities highlight the urgent need to enhance operations and reduce administrative burdens through AI and automation technology,” Marks said.